MedPath

The Effectiveness of AAD and IPV to Treat Hospitalized Infants (<2years) With Acute Viral Bronchiolitis.

Not Applicable
Completed
Conditions
Bronchiolitis
Interventions
Other: inhalation 4ml hypertonic saline 3% 3x/day
Device: Intrapulmonary Percussive Ventilation
Procedure: Assisted Autogenic Drainage
Registration Number
NCT02126748
Lead Sponsor
Vrije Universiteit Brussel
Brief Summary

The purpose of this study is to investigate the effectiveness of two airway clearance techniques; Intrapulmonary Percussive Ventilation and Assisted Autogenic Drainage in hospitalized infants under the age of 2 with acute viral bronchiolitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria
  • first period of wheezing
  • Wang score between 3 and 7
  • age < 24 months
  • Sa02> 90%
Exclusion Criteria
  • ICU patients
  • mechanical ventilation
  • use of antibiotics
  • use of corticosteroids
  • gestational age < 34 weeks
  • chronic cardiac or pulmonary disease
  • no parental consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intrapulmonary Percussive Ventilationinhalation 4ml hypertonic saline 3% 3x/day20 min of IPV administered to the patient inhalation 4ml hypertonic saline 3% 3x/day
Intrapulmonary Percussive VentilationIntrapulmonary Percussive Ventilation20 min of IPV administered to the patient inhalation 4ml hypertonic saline 3% 3x/day
Assisted Autogenic DrainageAssisted Autogenic Drainage20 min of AAD administered to the patient inhalation 4ml hypertonic saline 3% 3x/day
Assisted Autogenic Drainageinhalation 4ml hypertonic saline 3% 3x/day20 min of AAD administered to the patient inhalation 4ml hypertonic saline 3% 3x/day
Primary Outcome Measures
NameTimeMethod
Length of Hospital Stay6 days

Previously publised data ( Luo et al. 2011) showed that the average hospital stay for infants with acute viral bronchiolitis, inhaling 4 ml NaCl3%, three times /day is 6 days ( SD 1,2)

Secondary Outcome Measures
NameTimeMethod
Wang Scorebefore treatment, immediately after treatment and 1h after treatment
Heartratebefore, after and 1h after intervention
Oxygen Saturation (SaO2)before, after and 1h after treatment

oxygen saturation (SaO2) measured by pulse -oximetry

Trial Locations

Locations (1)

Uz Brussel

🇧🇪

Jette, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath